Supreme Court Won't Mull Hospira's Duty To Supply Drug

The U.S. Supreme Court on Tuesday declined to review the Eleventh Circuit's ruling that Hospira Inc. had no special duty to a proposed class of patients to supply an injectable form...

Already a subscriber? Click here to view full article